Laumas Sandeep insider trades

Laumas Sandeep has filed 14 Form 4s with the SEC that we hold, for Instil Bio, Inc. (TIL) (CFO and CBO), BioXcel Therapeutics, Inc. (BTAI) (Director) and Unicycive Therapeutics, Inc. (UNCY) (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $701.7K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 17,539 shares of Instil Bio, Inc. worth $404.1K, dated 2025-09-10. The first filing on our record is dated 2022-05-23 and the latest 2026-07-28.

Instil Bio, Inc. (TIL)

CFO and CBO · 6 filings · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2025-09-10	S, sale reported on Form 4	12,461	$297.6K	2025-09-12	SEC
2025-09-10	S, sale reported on Form 4	17,539	$404.1K	2025-09-12	SEC

BioXcel Therapeutics, Inc. (BTAI)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Unicycive Therapeutics, Inc. (UNCY)

Director · 4 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1721664) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-29 · For informational purposes only, not investment advice.
Privacy · Terms